Roux-en-Y gastric bypass surgery progressively alters radiologic measures of hypothalamic inflammation in obese patients

• Published in: JCI insight Vol. 4; no. 19
• Main Authors: Hankir, Mohammed K, Rullmann, Michael, Seyfried, Florian, Preusser, Sven, Poppitz, Sindy, Heba, Stefanie, Gousias, Kostantinos, Hoyer, Jana, Schütz, Tatjana, Dietrich, Arne, Müller, Karsten, Pleger, Burkhard
• Format: Journal Article
• Language: English
• Published: United States American Society for Clinical Investigation 03.10.2019
• Subjects: Neuroimaging; Obesity; Neuroscience; Metabolism
• ISSN: 2379-3708; 2379-3708
• DOI: 10.1172/jci.insight.131329

There is increased interest in whether bariatric surgeries such as Roux-en-Y gastric bypass (RYGB) achieve their profound weight-lowering effects in morbidly obese individuals through the brain. Hypothalamic inflammation is a well-recognized etiologic factor in obesity pathogenesis and so represents a potential target of RYGB, but clinical evidence in support of this is limited. We therefore assessed hypothalamic T2-weighted signal intensities (T2W SI) and fractional anisotropy (FA) values, two validated radiologic measures of brain inflammation, in relation to BMI and fat mass as well as circulating inflammatory (C-reactive peptide - CrP) and metabolic markers in a cohort of 27 RYGB patients at baseline, 6 months and 12 months after surgery. We found that RYGB progressively increased hypothalamic T2W SI values while it progressively decreased hypothalamic FA values. Regression analyses further revealed that this could be most strongly linked to plasma CrP levels which independently predicted hypothalamic FA values when adjusting for age, sex, fat mass and diabetes diagnosis. These findings suggest that RYGB has a major time-dependent impact on hypothalamic inflammation status possibly by attenuating peripheral inflammation. They also suggest that hypothalamic FA values may provide a more specific radiologic measure of hypothalamic inflammation than more commonly used T2W SI values.